Medtronic (MDT)
(Delayed Data from NYSE)
$89.76 USD
-0.10 (-0.11%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $89.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Medtronic (MDT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$93.43 | $106.00 | $82.00 | 3.97% |
Price Target
Based on short-term price targets offered by 23 analysts, the average price target for Medtronic comes to $93.43. The forecasts range from a low of $82.00 to a high of $106.00. The average price target represents an increase of 3.97% from the last closing price of $89.86.
Analyst Price Targets (23)
Broker Rating
Medtronic currently has an average brokerage recommendation (ABR) of 2.39 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 28 brokerage firms. The current ABR compares to an ABR of 2.39 a month ago based on 28 recommendations.
Of the 28 recommendations deriving the current ABR, 10 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 35.71% and 3.57% of all recommendations. A month ago, Strong Buy made up 35.71%, while Buy represented 3.57%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 10 | 10 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 15 | 15 | 15 | 13 | 13 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 2 | 2 | 2 | 3 | 3 |
ABR | 2.39 | 2.39 | 2.39 | 2.44 | 2.44 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/9/2024 | BTIG | Ryan Zimmerman | Hold | Hold |
8/23/2024 | Daiwa America | Narumi Nakagiri | Not Available | Strong Buy |
8/23/2024 | Truist Securities | Richard Newitter | Hold | Hold |
8/21/2024 | Robert W. Baird & Co. | David Rescott | Hold | Hold |
8/21/2024 | William Blair | Margaret Kaczor | Hold | Hold |
8/21/2024 | Not Identified | Not Identified | Hold | Hold |
8/21/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
8/21/2024 | Piper Sandler | Matthew O'Brien | Hold | Hold |
8/20/2024 | Not Identified | Not Identified | Hold | Hold |
8/19/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/15/2024 | UBS | Danielle Antalffy | Strong Sell | Hold |
8/14/2024 | Not Identified | Not Identified | Hold | Hold |
7/12/2024 | Mizuho SecuritiesUSA | Anthony Petrone | Strong Buy | Strong Buy |
7/10/2024 | Not Identified | Not Identified | Hold | Hold |
6/26/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/30/2024 | Goldman Sachs | David H Roman | Not Available | Strong Sell |
5/24/2024 | Not Identified | Not Identified | Strong Sell | Strong Sell |
5/24/2024 | Not Identified | Not Identified | Hold | Hold |
5/24/2024 | Needham & Company | Michael Matson | Hold | Hold |
4/1/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
3/15/2024 | Evercore Partners | Vijay Kumar | Strong Buy | Strong Buy |
3/14/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.39 |
ABR (Last week) | 2.39 |
# of Recs in ABR | 28 |
Average Target Price | $93.43 |
LT Growth Rate | 6.40% |
Industry | Medical - Products |
Industry Rank by ABR | 77 of 253 |
Current Quarter EPS Est: | 1.24 |
MDT FAQs
Medtronic PLC (MDT) currently has an average brokerage recommendation (ABR) of 2.39 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 28 brokerage firms.
The average price target for Medtronic PLC (MDT) is $93.43. The current on short-term price targets is based on 14 reports.
The forecasts for Medtronic PLC (MDT) range from a low of $82 to a high of $106. The average price target represents a increase of $4.09 from the last closing price of $89.76.
The current UPSIDE for Medtronic PLC (MDT) is 4.09%
Based on short-term price targets offered by 23 analysts, the average price target for Medtronic comes to $93.43. The forecasts range from a low of $82.00 to a high of $106.00. The average price target represents an increase of 3.97% from the last closing price of $89.86.